Action Point Financial Planning’s Cytokinetics CYTK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-32
Closed -$2.56K – 914
2026
Q2
$2.56K Buy
+32
New +$2.3K ﹤0.01% 2140

Other funds holding CYTK

Action Point Financial Planning's CYTK Position: Q3 2026 in Review

Action Point Financial Planning sold out of Cytokinetics (CYTK) in Q3 2026, closing a stake of 32 shares — an estimated $2.56K sold.

Action Point Financial Planning first reported a position in CYTK in Q2 2026 and held it in 1 quarter. The position peaked at $2.56K in Q2 2026. 473 funds tracked by Wall St. Rank hold CYTK as of Q3 2026.

  • Action Point Financial Planning reported no remaining Cytokinetics position as of Q3 2026 after selling out during the quarter.
  • Action Point Financial Planning sold 32 Cytokinetics shares in Q3 2026, an estimated $2.56K.
  • Action Point Financial Planning first reported a position in Cytokinetics in Q2 2026 and held it in 1 quarter.
  • Action Point Financial Planning's Cytokinetics position peaked at $2.56K in Q2 2026.
  • 473 funds tracked by Wall St. Rank held Cytokinetics as of Q3 2026.

Based on Action Point Financial Planning's 13F filing for Q3 2026, filed 13 Nov 2026.